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Abstract
Objective: MiR-21 is an oncomir expressed by malignant cells and/or tumor microenvironment components. In this study
we focused on understanding the effects of stromal miR-21 on esophageal malignant cells.
Design: MiR-21 expression was evaluated in formalin-fixed paraffin-embedded samples from patients with esophageal
squamous-cell carcinoma (SCC) by quantitative RT-PCR. MiR-21 tissue distribution was visualized with in situ hybridization. A
co-culture system of normal fibroblasts and esophageal cancer cells was used to determine the effects of fibroblasts on miR-
21 expression levels, and on SCC cell migration and invasion.
Results: MiR-21 was overexpressed in SCCs, when compared to the adjacent non-tumor tissues (P = 0.0007), and was mainly
localized in the cytoplasm of stromal cells adjacent to malignant cells. Accordingly, miR-21 expression was increased in
tumors with high versus low stromal content (P = 0.04). When co-cultured with normal fibroblasts, miR-21 expression was
elevated in SCC cells (KYSE-30), while its expression was restricted to fibroblasts when co-cultured with adenocarcinoma
cells (OE-33 and FLO-1). MiR-21 was detected in conditioned media of cancer cell lines, illustrating the release of this miRNA
into the environment. Co-culturing with normal fibroblasts or addition of fibroblast conditioned media caused a significant
increase in cell migration and invasion potency of KYSE-30 cells (P,0.0001). In addition, co-culturing cancer cells with
fibroblasts and expression of miR-21 induced the expression of the cancer associated fibroblast (CAF) marker S100A4.
Conclusions: MiR-21 expression is mostly confined to the SCC stroma and its release from fibroblasts influences the
migration and invasion capacity of SCC cells. Moreover, miR-21 may be an important factor in ‘‘activating’’ fibroblasts to
CAFs. These findings provide new insights into the role of CAFs and the extracellular matrix in tumor microenvironment
formation and in tumor cell maintenance, and suggest miR-21 may contribute to cellular crosstalk in the tumor
microenvironment.
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Introduction
MicroRNAs (miRNAs) are short (,22 nucleotides), endogenous
non-coding RNAs, which act as post-transcriptional modulators of
a variety of cellular processes including development, proliferation,
differentiation and apoptosis [1–3]. Although microRNAs were
initially found to inhibit translation or degrade their mRNA
targets by imperfect or perfect complementary binding, new
publications have assigned other regulatory roles for miRNAs,
including promoter companionship [4]. Alterations in the
expression of miRNAs are associated with a variety of diseases
including cancer, where they show tumor-specific expression
signatures. Therefore, targeting miRNAs might hold great
diagnostic and therapeutic promise [5–7].
Increasing evidence implicates miR-21 as an ‘‘oncomir’’ in
tumorigenesis, where it is found to be upregulated in the majority
of analyzed cancers, including glioblastoma, colorectal, breast and
pancreatic cancer [8–13]. By regulating different targets, miR-21
is involved in cellular proliferation, evasion of apoptosis, epithelial
to mesenchymal transition (EMT), and invasion [8,14–16].
At the cellular level, the majority of studies focused on miR-21
overexpression in cancer, where, according to its oncogenic role
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in tumorigenesis, the highest miR-21 expression levels are
expected in tumor cells [17–18]. However, in breast and colon
cancer miR-21 has also been localized to cancer associated
fibroblast-like cells (CAFs) [19–21]. These fibroblasts facilitate
communication between the tumor cell and the tumor microen-
vironment, and thus support tumor progression, angiogenesis and
metastasis. These findings point to a dynamic role of miR-21 in
malignant behavior through stimulation of cancer cell prolifer-
ation and extracellular matrix (ECM) remodeling [19–21].
However, the precise role of miR-21 at the tissue level still
needs to be elucidated. Among the well characterized molecular
targets of miR-21 are tropomyosin 1 (TPM1) [22], tissue
inhibitor of metalloproteinase 3 (TIMP3) [23–24], and compo-
nents of the transforming growth factor beta (TGFb) pathway
[25]. TGFb can induce apoptosis or proliferation, depending on
the cellular context and the specific state of the cells. In addition,
miR-21 can increase TGFb signaling through targeting SMAD
[26–28].
Esophageal squamous cell carcinoma (ESCC) is an aggressive
type of epithelial cancer that is characterized by scarce overall
survival and a low rate of response to (neo-) adjuvant therapy [29].
Hence, there is a great need for a multimodal treatment. In recent
years, several molecular markers have been introduced as
predictive and prognostic targets in patients with esophageal
cancer [30].
Iran, and the Golestan province in particular, has one of the
highest rates of esophageal cancer (EC) in the world [31].
Therefore, the aim of the current study was to analyze the
expression of miR-21 in SCC samples of Iranian patients and to
explore whether stromal-expressed miR-21 has an influence on the
behavior of the malignant cells.
Materials and Methods
Clinical sample collection
A total of 42 formalin-fixed paraffin-embedded (FFPE) tissue
samples of patients with esophageal SCC were collected from the
archive of the Namazi hospital (Shiraz University of Medical
Sciences, Iran). Hematoxylin and eosin (H&E) stained histopath-
ological sections of each sample were further studied by an expert
pathologist (MV) to delineate the tumor/non-tumor areas as well
as the histopathological criteria of each sample. The pathological
characteristics of the SCC patient samples are summarized in
Table 1. The paired tumor and non-tumor areas of each FFPE
block were carefully macro-dissected and transferred to an RNase-
free microcentrifuge tube for RNA extraction.
Ethics statement
This study was reviewed and approved by the Ethical
Committee of Tarbiat Modares University. All samples were
collected according to the institutional policies. We used archival
FFPE samples that were collected 10–20 years ago, and most
patients deceased so no written consent could be obtained. Also, as
the Guidelines for Record and Specimen Retention suggest a
retention period for paraffin blocks and slides of 10 years [32], the
archived FFPE samples from this study could be studied without
any ethical concern. However, all patients from this study
provided verbal informed consent at the time of admission to
the hospital and the verbal consent procedure was reviewed and
approved by the Ethical Committee of Tarbiat Modares
University.
RNA extraction from esophageal FFPE specimens
First, samples were deparaffinized with xylol and digested with
Proteinase K solution (Fermentas, Lithuania). Several factors,
including the proteinase K/buffer composition, temperature and
digestion time, were altered to optimize the protein digestion
procedure. The following protocol was then used: incubation in
PK buffer (1 mM EDTA, 1 mM NaCl, 5 mM Tris-HCl, pH 7.4)
supplemented with 15 mg/ml of proteinase K for 3 hours at 54uC.
RNA was then extracted from deparaffinized tissue with TRIzol
reagent (Invitrogen, USA) according to the manufacturer’s
instructions.
MiR-21 quantification in FFPE samples by quantitative
RT-PCR
After treatment with DNase I (Fermentas, Lithuania; manu-
facturer’ s recommendations), 100 ng of total RNA was subjected
to qRT-PCR, using a two-step protocol of universal cDNA
synthesis and SYBR green master mix kits, along with specific
locked nucleic acid (LNA) PCR primer sets (Exiqon, Denmark)
on an ABI 7500 real-time PCR machine. To evaluate the
possibility of contamination by any RT-PCR inhibitors, an RNA
spike-in (UniSp6; Exiqon, Denmark) was added to the samples
prior to cDNA synthesis (108 copies per 20 ng RNA) and qRT-
PCR was performed with spike-in PCR primer sets (Exiqon,
Denmark) as well.
For each sample a no-reverse transcription (no-RT) control
was used to detect any potential non-specific amplification of
genomic DNA. 5S rRNA and U6 snRNA were used as internal
controls for data normalization in FFPE and cell culture samples,
respectively.
In situ hybridization on FFPE samples of esophageal SCC
Deparaffinization by xylol and Proteinase K digestion
(Fermentas, Lithuania) were performed as described in a previous
section of the Experimental Procedures. Slides were then
incubated with 59 digoxigenin (DIG)-labeled miRCURY LNA
microRNA detection probes (Exiqon, Denmark), which were
diluted to 50 nM in hybridization buffer (50% Formamide, 5X
SSC, 0.1% Tween-20, 9.2 mM citric acid, 50 mg/mL heparin,
500 mg/mL yeast RNA) for 1h in a ThermoBrite hybridizer
(Fisher Scientific, USA). LNA antisense oligonucleotides were
Table 1. Histopathological criteria of the analyzed SCC patients.
Differentiation level Stroma level Inflammation level
Patient samples Poor (high grade)
Moderate (intermediate
grade) Well (low grade) Low High Low High
Number 12 4 26 11 31 26 16
Percentage 28.57% 9.52% 60.9% 26.19% 73.81% 61.9% 38.1%
doi:10.1371/journal.pone.0073009.t001
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used to increase the oligo-miRNA binding affinity. The probe
sequences were the following:
hsa-miR-21 probe: 59-TCAACATCAGTCTGATAAGCTA-
39hsa/mmu/rno-U6 snRNA probe: 59-CACGAATTTGCGTG
TCATCCTT-39.
A stringency wash was performed in descending serial dilutions
of standard sodium citrate (SSC) buffer. After blocking unspecific
binding of the antibody with sheep serum (Sigma, USA),
immunological detection with alkaline phosphatase (AP)-conju-
gated sheep anti-DIG antibody (Roche, Germany) was carried out
overnight at 4uC. A light-sensitive color reaction with 4-nitroblue
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (NBT/
BCIP) ready-to-use tablets (Roche, Germany) was performed for
3 hours at 30uC in a humidified chamber.
Cell culture conditions and cell lines
The KYSE-30 esophageal SCC cell line was obtained from the
National Cell Bank of Iran, and cultured in RPMI 1640 (Gibco,
USA) and Ham’ s F12 (Invitrogen, USA) (1:1) supplemented with
10% fetal bovine serum (FBS) (Sigma, USA). The esophageal
adenocarcinoma cell lines OE-33 and FLO-1 originated from the
American Type Culture Collection (ATCC) and were kindly
provided by Dr. Dipen Maru (Department of Pathology, The
University of Texas MD Anderson Cancer Center, Houston, TX,
USA). OE-33 and FLO-1 were cultured in RPMI 1640 and
DMEM Dulbecco’ s Modified Eagle Media (Gibco, USA)
supplemented with 10% FBS, respectively. Human normal
fibroblasts of gingiva (HGF-1) were obtained from the American
Type Culture Collection (ATCC) and cultured in DMEM
supplemented with 10% FBS.
The conditioned media from HGF-1 fibroblasts and the
esophageal cancer cell lines, containing secreted growth factors,
were collected at different time points, centrifuged for 5 min at
1500 rpm, equally mixed with fresh media and used for further
experiments.
MiR-21 quantification in cell lines
For microRNA quantification in cell lines, a miR-21 and U6
snRNA specific reverse transcription reaction with MultiScribe
Reverse Transcriptase and microRNA specific primers (Applied
Biosystems, USA) was performed on 50 ng of total RNA.
Quantitative RT-PCR was carried out with a Taqman assay
(primers and probes) (Applied Biosystems, USA) and SsoFast
Probe Supermix (BioRad, USA) according to manufacturer’s
protocol.
Co-culture of esophageal cancer cell lines with normal
human gingival fibroblasts (HGF-1)
To evaluate the effect of normal fibroblasts on miR-21
expression levels, we separately juxtaposed all 3 esophageal SCC
and adenocarcinoma cell lines with HGF-1 fibroblast cells in a
Transwell system. In this system, HGF-1 cells were seeded in the
wells of a 12-well plate, while esophageal cancer cells were
seeded in the 0.4 mm pore-sized inserts (BD Biosciences, USA)
that were placed in each well to avoid physical contact between
the two cell types. Both fibroblasts and cancer cells were
harvested after 1, 2 and 3 days of incubation. The time point
day 1 after co-culture was considered as a reference for
comparison.
To overcome the effects of the use of different media on cell
stress in the co-culture experiments, OE-33 and KYSE-30 cells,
normally cultured in RPMI 1640 supplemented with 10% FBS
and in RPMI 1640/Ham’ s F12 (1:1) supplemented with 10%
FBS, respectively, were adapted to DMEM medium supple-
mented with 10% FBS. In three consecutive passages, cells were
grown in mixtures of RPMI 1640 and DMEM supplemented
with 10% FBS in a 3:1, 1:1 and 1:3 ratio, respectively. From the
fourth passage onwards, cells were cultured in DMEM supple-
mented with 10% FBS.
Evaluating fibroblastic markers and CAF markers in HGF-
1 cells
PCR primers for the fibroblast markers TGFb1 (MIM: 190180),
FGF1 (MIM: 131220), STAT3 (MIM: 102582), STAG2 (MIM:
300826), TIMP3 (MIM: 188826), COL4A1 (MIM: 120130) and for
the CAF markers ACTA2 (MIM: 102620), FAP (MIM: 600403),
S100A4 (MIM: 114210) and CSPG4 (MIM: 601172) were designed
over exon boundaries in order to amplify the most common
splicing variants of each gene without amplifying the genomic
DNA. Primer sequences for the fibroblast markers can be found in
Table S1, CAF marker primer sequences are available upon
request. Each primer pair was validated and all PCR products
were confirmed by Sanger sequencing (Figure S1; data not
shown).
Gene expression quantification was performed with SuperScript
III reverse transcriptase (Invitrogen, USA) for the reverse
transcription reaction and iQTM SYBR Green Supermix (Biorad,
USA) for qRT-PCR. b2M was, among 8 common normalizers
(PGK1, HPRT1, GUSB, PPIA, RPLPO, TBP, b2M and b Actin) and
based on Cq values (Figure S2), selected as the best internal
control for these experiments. Primer sequences of the normalizers
are available upon request.
All of the fibroblastic markers were predicted by databases
(TargetScan and/or DIANA-microT) to be potentially targeted by
miR-21, and some of them have already been validated as miR-21
targets.
RNA extraction and miR-21 quantification from
conditioned medium
The conditioned media from KYSE-30 and HGF-1 cells was
harvested after 1, 2 and 3 days, centrifuged for 5 minutes at
1500 rpm and kept at 220uC for further experiments. RNA was
extracted from 300 ml of conditioned medium with the Total RNA
Purification Kit (Norgen, Canada). A mixture of 25 fmol of the
synthetic C. elegans microRNAs cel-miR-39 and cel-miR-54
(Ambion, USA) were spiked in all samples immediately after
adding lysis buffer. 10 ng of each sample was used for qRT-PCR
analysis in which the synthetic miRNAs (Applied Biosystems,
USA) were used as internal controls. Data were normalized to the
expression in the 6 hour old media from each cell line.
Migration assay
To determine the effects of normal fibroblasts on KYSE-30
migration, 7.56104 fibroblasts were seeded in 24-well plates. The
next day, 7.56104 KYSE-30 cells were seeded in the upper
chamber of Transwells with 8 mm pore size, which were uniformly
coated with 0.1% gelatin (BD Biosciences, USA) and placed in the
wells in which the fibroblasts were growing. KYSE-30 cells that
were not co-cultured with fibroblasts were used as controls. After
16 hours of incubation, the membranes were fixed and stained
using the Hema3 manual staining system (Fisher Scientific, USA).
With a cotton swap, the cells in the upper surface of each
membrane were removed and the cells on the bottom surface were
counted under the microscope.
MiR-21 in Esophageal Cancer
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Invasion assay
In this assay, the 8 mm pore-sized Transwell membranes (BD
Biosciences, USA) were coated evenly with a matrix containing
type IV collagen, human laminin and gelatin (Sigma, USA).
6.256104 cells were seeded in the upper chamber and co-cultured
with previously seeded HGF-1 cells. The cells were fixed and
stained after 20 hours of incubation with the aforementioned
protocol for migration.
Statistical analyses
For qRT-PCR analysis, at least 3 experiments were performed
in triplicate and statistical analysis was carried out on DCq data.
The reaction efficiencies for miRNA expression were determined
with the LinRegPCR software (Amsterdam, The Netherlands,
Version 12.12) (Table S2). Group-wise comparison between
tumors and their non-tumor counterparts as well as statistical
analysis of relative expression were performed with the ‘‘Relative
Expression Software Tool’’ (REST) (Qiagen, Germany, Version
2.0.13). We used Microsoft Excel to analyze miR-21 expression
levels in different cell culture experiments. The statistical
difference between groups was determined by unpaired t test or
unpaired t test with Welch’s correction (when the data had
significant unequal variances) and P values of less than 0.05 were
considered as statistically significant. Data represent the mean +/
2 standard deviation (SD) of at least three independent
experiments performed in duplicates or triplicates.
Results
MiR-21 is upregulated in esophageal tumor tissues
Quantitative RT-PCR analysis on total RNA demonstrated a
significant overexpression of miR-21 in esophageal SCC samples,
in comparison to the adjacent, histologically normal tissues of the
same patients (P = 0.007, Figure 1). We also compared the miR-
21 expression levels in low- vs. high-grade tumors and found that
miR-21 expression levels did not discriminate between well
differentiated (considered as low-grade) and poorly differentiated
(high-grade) tumors (P.0.05) (data not shown), suggesting that
miR-21 overexpression is an early event in the tumorigenesis of
esophageal tissue.
MiR-21 is mainly localized in the cancer associated
fibroblasts
Using specific LNA-oligo probes against miR-21, we analyzed
endogenous miR-21 expression in the FFPE sections prepared
from either tumor or non-tumoral esophageal samples. In situ
hybridization (ISH) demonstrated a primarily cytoplasmic signal of
miR-21 in tumor regions; however, the signal was mainly found in
cancer associated fibroblasts (CAFs) of the tumor stroma, with
much weaker signals in the tumor cells (Figure 2A). The stroma
of apparent normal squamous tissue showed no detectable signal
(Figure 2B), suggesting a preferential upregulation of miR-21 in
stromal fibroblasts adjacent to the tumor cells. This was observed
in all analyzed samples (N= 6, Figure S3). The nuclear
localization of U6 snRNA was used as an internal control
(Figure 2C), and slides without probe treatment were used as
negative controls (Figure 2D).
MiR-21 expression levels are correlated with the stromal
proportion of the tumors
Next, we re-examined miR-21 expression in the esophageal
FFPE samples with different stromal ratios. Based on the stromal
contents, determined by an expert pathologist for each sample, we
categorized the samples into two groups: high stroma (more than
50%) vs. low stroma. The obtained qRT-PCR data demonstrate
that miR-21 levels are significantly higher in tumors with high
stroma (P= 0.04), as compared to those with low levels of stroma
(Figure 2E).
Induction of miR-21 expression in a co-culture assay of
esophageal cancer cells and normal fibroblasts
To examine whether the tumor microenvironment has a role
on miR-21 intra-tumor distribution, we used a co-culture system
in which the fibroblasts that were cultured in a 12-well plate
shared the media with the KYSE-30 cells that were grown on an
insert located within the same well (Figure 3A). We then
compared miR-21 expression in this co-culture system with miR-
21 expression in fibroblasts grown without KYSE-30 cells. The
fibroblasts showed a significant upregulation of miR-21 when
grown in a co-culture system with KYSE-30 (P = 0.04;
Figure 3B, black bars). Interestingly, we found a similar
and significant effect of fibroblasts on the expression levels of
miR-21 in KYSE-30 cells (P = 0.02; Figure 3B, white bars).
This upregulating effect on miR-21 expression was even more
obvious for HGF-1 fibroblast cells co-cultured with FLO-1 cells
(Figure 3D). However, these differences were not statistically
significant.
To understand the nature of this micro-environmental effect, we
added conditioned media (CM) obtained from the normal
fibroblasts to the esophageal SCC cell line KYSE-30 and to the
adenocarcinoma cell line FLO-1. As shown in Figure 3C, the
fibroblast conditioned media induces miR-21 expression in the
KYSE-30 cells (white bars), with longer conditioning period
leading to higher miR-21 expression. Moreover, treatment of
HGF-1 cells with CM from FLO-1 induced higher expression
levels of miR-21 in the HGF-1 fibroblasts (Figure 3E, black
bars). The basic miR-21 expression levels were not significantly
different in all 4 cell lines used in these experiments (Figure S4).
Altogether, these results indicate that the effect of neighboring
fibroblasts on the cancer cells might be different in different
histological subtypes.
Figure 1. Differential expression of miR-21 in 42 FFPE tumor
samples in comparison with adjacent non-tumoral tissue.
Quantitative RT-PCR analysis on FFPE samples of esophageal SCC
patients shows higher levels of miR-21 in cancerous tissue as compared
to the adjacent non-cancerous counterpart (P = 0.0007). MicroRNA
levels are normalized to 5S rRNA. Values are presented as means 6
standard deviation. The P value was determined with a 2-tailed Student’
s t-test.
doi:10.1371/journal.pone.0073009.g001
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Both cancer cells and normal fibroblasts can release miR-
21 into the environment
Quantitative RT-PCR on RNA extracted from the conditioned
media of fibroblast cultures showed an up to 8.4 fold overexpres-
sion of miR-21 after 3 days of incubation, relative to the media
which was collected from the same cell passage after 6 hours of
culturing (P = 0.02). In addition, we observed a 9.3 fold increase in
miR-21 expression in the 3 day old conditioned media from
KYSE-30 cells, relative to the media collected from the same cell
passage after 6 hours, but this increase was not significant
(Figure S5).
Figure 2. MiR-21 expression is mainly confined to the tumor stroma. A) In situ hybridization in FFPE samples of esophageal cancer localized
miR-21 expression (blue signals) in cancer associated fibroblasts of the tumor stroma, but not in the tumor cells. Slides were counterstained with
nuclear fast red. B) The adjacent normal squamous part on the same slide did not show miR-21 expression neither in the stroma nor in the squamous
cells; C) Nuclear staining of U6 snRNA was used as an internal control; D) Negative control without probe. Bottom-left inserts show a 2 times bigger
magnification of each image; E) Samples with high stromal component showed significantly higher levels of miR-21 expression than samples with a
low stromal content. (P value = 0.04 with unpaired T-test with Welch’ s correction).
doi:10.1371/journal.pone.0073009.g002
MiR-21 in Esophageal Cancer
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Normal fibroblasts as well as conditioned media from
normal fibroblasts can potentiate migration and invasion
of neighboring cancer cells
While juxtaposed with normal fibroblasts, KYSE-30 cells show
a significantly higher propensity to migrate and invade through the
matrix, which simulates the ECM. KYSE-30 cells not juxtaposed
with normal fibroblasts were used as negative controls (Figure 4A).
Incubation of KYSE-30 cells with the conditioned media of HGF-
1 fibroblast cells also results in significantly higher rates of
migration (P,0.0001) and invasion (P,0.0001) of KYSE-30 cells
through the matrix (Figure 4B). To investigate the role of
induced miR-21 in the capacity of KYSE-30 cells to migrate and
invade through the matrix, we inhibited miR-21 in HGF-1 prior
to co-culturing with KYSE-30. We found that miR-21 was
significantly downregulated at the end of the experiment
(Figure S6A–B) and that KYSE-30 cell migration and invasion
was reduced, although this reduction was not significant (Figur-
e S6C–D). In addition, TIMP3 and COL4A1 seem to be increased
in HGF-1 cells treated with miR-21 inhibitor and co-cultured with
KYSE-30 (Figure S6E–F).
Figure 3. Effect of co-culturing normal fibroblasts with esophageal cancer cell lines on miR-21 expression levels. A) A schematic view
of the co-culture system; B) MiR-21 expression in KYSE-30 cells and normal fibroblasts (HGF-1) after juxtaposition in a co-culture system; C) MiR-21
expression levels in KYSE-30 and HGF-1 cells after treatment with CM of HGF-1 and KYSE-30 cells, respectively; D) MiR-21 expression levels in FLO-1
adenocarcinoma and HGF-1 fibroblast cells after juxtaposition in a co-culture system; E) MiR-21 expression levels in FLO-1 and HGF-1 cells after
treatment with CM of HGF-1 and FLO-1 cells, respectively. Data were normalized to expression after 24 h of co-culture. Each experiment was
performed at least 2 times in triplicates.
doi:10.1371/journal.pone.0073009.g003
MiR-21 in Esophageal Cancer
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The fibroblastic markers TIMP3 and COL4A1 showed
decreased expression levels in the co-culture system
We first selected 6 fibroblastic markers that were predicted by
target prediction databases (Targetscan and/or DIANA-MicroT)
to be potential targets for miR-21: TGFb1, transforming growth
factor beta1; FGF1, acidic fibroblast growth factor 1; STAT3,
signal transducer and activator of transcription 3; STAG2, stromal
antigen 2; TIMP3, tissue inhibitor metalloproteinase 3; and
COL4A1, Collagen, type IV, alpha 1. We then analyzed the
expression of these 6 fibroblastic markers in the normal fibroblast
cell line HGF-1, as well as in HGF-1 cells co-cultured with KYSE-
Figure 4. Cell migration and invasion properties of KYSE-30 cells are increased upon co-culture with HGF-1. A) KYSE-30 cells
juxtaposed with HGF-1 fibroblasts showed a significantly higher potential to migrate (P,0.0001) or invade (P = 0.0001) through the coated 8.0 mm
pore-sized membrane as compared to the KYSE-30 cells not grown co-culture with normal fibroblasts. Images of representative microscopic pictures
are shown on the left; B) 3 day old conditioned media from HGF-1 fibroblasts could significantly induce migration and invasion of KYSE-30 cells
(P,0.0001 for both experiments). Images of representative microscopic pictures are shown on the left.
doi:10.1371/journal.pone.0073009.g004
MiR-21 in Esophageal Cancer
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30, FLO-1 and OE-33, and found that HGF-1 normal fibroblasts
expressed all 6 selected markers. Interestingly, TIMP3 and
COL4A1 expression was reduced on the second and third day of
incubation compared to the expression levels at the first day of co-
culture (Figure 5). In addition, this reduction was negatively
correlated with the expression of miR-21 in HGF-1 fibroblast cells
co-cultured with any cell lines (KYSE-30, FLO-1 and OE-33)
(Figure 3; data not shown). We then analyzed TIMP3 and
COL4A1 protein expression in the HGF-1 – KYSE-30 and HGF-
1 – FLO-1 co-culture systems and could not detect any TIMP3
protein, while COL4A1 was expressed, but the expression was not
altered due to co-culture (Figure S7). The four other fibroblastic
markers had similar and stable expression levels during the co-
culture experiment, suggesting that their expression levels were not
affected by the presence of cancer cells.
Co-culture with cancer cells and expression of miR-21
induce the CAF marker S100A4 in HGF-1 fibroblasts
To investigate whether a CAF phenotype can be induced in
normal fibroblasts, we co-cultured KYSE-30 cells and normal
HGF-1 fibroblasts, and analyzed the expression of 4 CAF markers
in HGF-1. Since signatures greatly vary depending on the tissue of
origin [33–34] and since no ESCC-associated CAF markers have
been identified so far, we selected 4 markers that have been found
to be either ‘general’ CAF markers or oral/esophageal CAF
markers [33,35–37]: ACTA2 (or alpha-SMA), FAP, S100A4 (or
FSP1) and CSPG4 (or NG2). Only S100A4 seems to be induced in
HGF-1 fibroblasts both on RNA and protein level upon co-culture
(Figure S8A–B). Moreover, up- or down-regulation of miR-21 in
HGF-1 fibroblasts results in increased (Figure S8C) or decreased
(Figure S8D) levels of S100A4, respectively. These results suggest
that fibroblasts may be ‘‘activated’’ into a CAF phenotype, when
residing in the proximity of cancer cells, and that miR-21 may be
an important factor in this process.
Discussion
In this study, we demonstrated that miR-21 is upregulated in
esophageal tumors and that this upregulation is mainly confined
to the cancer associated fibroblasts. MiR-21 overexpression has
been reported in a variety of cancers including esophageal
carcinoma (Table 2) [10,13,38–43], but only recently, scientists
have started to study the miR-21 tissue localization pattern [20–
21]. Previous studies in breast, lung and colon cancers have
localized miR-21 mainly in the tumor stroma and more
particularly in the stromal fibroblast-like cells. This localization
may be due to factors secreted by cancer cells, which affect their
microenvironment [20–21,44–45]. On the contrary, Dillhof et al.
and Qi et al. reported miR-21 expression in pancreatic and
breast cancer cells but not in the surrounding stroma [8,46]. Our
in situ hybridization data detected miR-21 expression in
fibroblast-like stromal cells adjacent to cancer cells. Accordingly,
we detected significant miR-21 overexpression in FFPE tumor
samples with high stromal content when compared to the
samples with low stroma, further supporting the primary
localization of miR-21 in the stromal components. Therefore, if
more accurate data on miR-21 quantification in different tumor
tissue samples is desired, the stromal content of the samples must
be taking into account.
The tumor fibroblasts are ‘‘activated’’ normal cells that
represent a modified state and are also termed peri-tumoral
fibroblasts, reactive stromal fibroblasts or cancer associated
fibroblasts (CAFs). CAFs facilitate the communication between
tumor cells through cell-cell contact or paracrine/exocrine
signaling, protease secretion and modulation of the extracellular
matrix (ECM) [35,47]. Yamamichi et al. and Yang et al. detected
overexpression of miR-21 in CAFs from colorectal cancer and
melanoma, respectively, and suggested that this deregulation could
be caused by cancer-secreted cytokines [45,47]. Nevertheless, the
mechanisms of action of miR-21 in CAFs still remain unknown.
To unravel the contribution of miR-21 to the properties of the
tumor stroma, we used a co-culture system for the KYSE-30
Figure 5. Expression analysis of 6 fibroblastic markers in
normal fibroblasts co-cultured with esophageal cancer cell
lines KYSE-30 (A), FLO-1 (B) and OE-33 (C). COL4A1 expression in
fibroblasts was significantly decreased after 2 days of incubation with
KYSE-30 (P = 0.03) and OE-33 (P = 0.04) cells and after 3 days of
incubation with FLO-1 cells (P = 0.01). TIMP3 expression was significantly
decreased after 2 and 3 days of incubation with KYSE-30 (P = 0.0002 and
P.0.0001, respectively), after 2 and 3 days of incubation with FLO-1
cells (P = 0.0013 and P= 0.0006, respectively) and after 2 and 3 days of
incubation with OE-33 cells (P = 0.0017 and P= 0.0004, respectively)
when compared to the measurement 24 h after the start of the co-
culture.
doi:10.1371/journal.pone.0073009.g005
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esophagus cell line and normal fibroblasts (HGF-1). Quantitative
RT-PCR demonstrated miR-21 overexpression in both cell lines
when co-cultured, but the impact of normal fibroblasts on KYSE-
30 cells was clearly stronger. Moreover, the conditioned media
without cells had a similar effect on KYSE-30 cells, which may
highlight a role of normal fibroblasts in the tumor microenviron-
ment by producing necessary factors that help promoting cancer
progression and invasion. KYSE-30 cells that are co-cultured with
normal fibroblasts show a higher propensity to migrate and invade
through the matrix, which is a model for the ECM. Moreover,
omitting the cells from this system and only incubating with the
conditioned media from fibroblasts had similar effects on
migration and invasion of cancer cells as the co-culture system.
It has been demonstrated that miR-21 can be secreted within
exosomes and can directly bind to Toll-like receptors, which are
expressed on the cell surface of the immune cells, triggering an
inflammatory response which leads to tumor growth and
metastasis [48]. This may be important for the higher propensity
of KYSE-30 cells to migrate and invade in our co-culture system.
By targeting distinct molecules such as matrix metalloproteinase
regulators TIMP3 and TIAM1 [23,25], miR-21 plays an essential
role in cancer progression and metastasis.
In a co-culture system, we detected a time-dependent increase
in miR-21 expression in the HGF-1 fibroblasts when co-cultured
with the adenocarcinoma cell line FLO-1 while KYSE-30 cells
showed a time-dependent increase of miR-21 expression when co-
cultured with HGF-1 fibroblasts. This might be due to the
inherent differences between in vitro and in vivo systems, which alter
gene expression patterns. These patterns might be histology-
dependent, and different histological types of cancer might have
different levels of miR-21 expression.
We observed a downregulation of TIMP3 and COL4A1 in
normal fibroblasts that were juxtaposed to esophageal cancer cells
and this downregulation is consistent with the duration of co-
culture and with the increase of miR-21 in the system. Both
TIMP3 and COL4A1 are components of the ECM, and are
validated as direct targets of miR-21 [15,24,49–51]. In this regard,
we suggest that the vicinity of cancer cells can induce normal
fibroblasts to become ‘‘active fibroblasts’’, which produce higher
levels of specific markers, including TIMP3 and COL4A1. With
gradual induction of miR-21 in the system, these fibroblast
markers are downregulated. However, as we cannot exclusively
point out miR-21 as the only liable molecule for this downreg-
ulation, our observations need future refinement [23,52].
Previously, TGFb has been considered as the major regulator of
the tumor microenvironment, thereby promoting tumor develop-
ment and tumor growth [53–54]. TGFb overexpression induces
miR-21 processing, which in turn blocks apoptosis pathways and
some tumor suppressor genes in cancer cells [26]. We detected
miR-21 in the media of both cancer and normal cells, supporting a
probable role of this miRNA as a signaling molecule in the tumor
microenvironment.
S100A4, also known as fibroblast-specific protein 1 (FSP1), is a
small acidic calcium-binding protein that transduces Ca(2+)-
signals via interaction with intracellular target proteins [55] that
has previously been described as a CAF marker associated with
clinical outcome of cancer patients [56]. We detected higher levels
of the CAF marker S100A4 in HGF-1 fibroblasts co-cultured with
KYSE-30 or transfected with miR-21 precursor, and reduced
expression when miR-21 was inhibited in HGF-1 fibroblast. This
finding highlights the role of miR-21 in the induction of a CAF
phenotype.
In conclusion we report that miR-21 is a microenvironment
signaling molecule that contributes to tumor growth and cancer
progression. Such data could lead to the development of new
assays measuring miR-21 levels in tumoral stroma and/or body
fluids for the prediction of SCC metastasis and survival.
Supporting Information
Figure S1 Primer validation for fibroblast specific
marker genes. Primer efficiencies were calculated according
to the standard curves for each pair of primers: A) TGFb1, B)
FGF1, C) STAT3, D) STAG2, E) TIMP3 and F) COL4A1.
Quantitative RT-PCR was performed on serial concentrations of
cDNA (2.00E-01, 4.00E-02, 8.00E-03, 1.60E-03, 3.20E-04
Table 2. MiR-21 overexpression in different histological types of esophageal cancer.
Techniques Pathology Population Findings
Statistical
significance Fold change Ref.
miRNA bioarray ADC and SCC American Overexpression in
Tumor vs. Normal
NA 5.2 (ADC to NE) [13]
microarray ADC and SCC American/Canadian/
Japanese
Overexpression in
Tumor vs. Normal
P,0.005 .2 [38]
qRT-PCR SCC Japanese Overexpression in
Tumor vs. Normal
P,0.0001 6.87 [10]
microarray ADC American Overexpression in
Tumor vs. Normal
P = 0.03 1.73 [39]
microarray SCC Japanese and cell line Overexpression in
Tumor vs. Normal; also
in SCC cell line
P,0.05 NA [40]
qRT-PCR SCC Japanese Overexpression in
Tumor vs. Normal
P,0.05 .2 [41]
microarray SCC Chinese The most upregulated
miRNA
P,0.05 24.2 [42]
qRT-PCR SCC Iran Overexpression in
Tumor vs. Normal
P = 0.0007 2.77 Present
study
Abbreviations: ADC, adenocarcinoma; SCC, squamous cell carcinoma; NE, normal epithelium; NA, not available.
doi:10.1371/journal.pone.0073009.t002
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dilutions) and standard curves were analyzed with the BioRad
CFX Manager software. All the calculated efficiencies were within
the range of 90–110%.
(TIF)
Figure S2 Selection of internal control genes for HGF-1
cells. Eight different internal control genes were selected and
qRT-PCR was performed on untreated HGF-1 cells, HGF-1 cells
co-cultured with KYSE-30 (3 days of incubation) and HGF-1 cells
co-cultured with OE-33 (3 days of incubation). Mean Cq value of
each gene is shown in the graph. HPRT1 had the lowest standard
deviation (SD) but the Cq values were high. Therefore b2M was
selected as the best normalizer gene with lowest SD, stable
expression in all 3 analyzed samples and appropriate Cq values.
(TIF)
Figure S3 In situ hybridization on FFPE tissue samples
of 6 patients shows miR-21 upregulation in the stroma of
the tumor but not in the stroma of adjacent normal
squamous tissue. The black arrows in the 406magnification
figure (right-bottom figure) show blue miR-21 signals in the
cytoplasm of the fibroblasts.
(TIF)
Figure S4 Basic expression of miR-21 in the FLO-1, OE-
33, KYSE-30 and HGF-1 cell lines. A) miR-21 was expressed
in all analysed cell lines under normal conditions; data were
normalized to U6 in each cell line; B) Mean Cq values for U6
expression in four analyzed cell lines. There is no significant
difference in miR-21 expression between 4 cell lines.
(TIF)
Figure S5 MiR-21 expression analysis in conditioned
media obtained from HGF-1 and KYSE-30 cells. Condi-
tioned media of each cell line was collected from the same cell
passage after 1, 2 and 3 days of incubation. All data were
normalized to the 6 hour-old media which was set as time point 0.
MiR-21 is significantly upregulated in conditioned media of
normal HGF-1 fibroblast cells after 3 days of incubation
(P = 0.02). In the conditioned media of KYSE-30 cells we observed
higher miR-21 expression after 3 days of incubation, but this
increase was not significant. P values were calculated with an
unpaired t test with Welch’ s correction.
(TIF)
Figure S6 Migration and invasion assay for KYSE-30
cells co-cultured with HGF-1 fibroblasts in which miR-
21 has been inhibited. MiR-21 expression is significantly
reduced in HGF-1 cells treated with miR-21 inhibitor during the
migration (A) and invasion (B) assay. Cell migration (C) and
invasion (D) properties of KYSE-30 seem to be reduced when co-
cultured with HGF-1 cells in which miR-21 has been inhibited.
TIMP3 and COL4A1 seem to be increased in HGF-1 cells treated
with miR-21 inhibitor and co-cultured with KYSE-30 in the
migration (E) and invasion (F) assay. NC inh, negative control inhibitor;
miR-21 inh, miR-21 inhibitor.
(TIF)
Figure S7 TIMP3 and COL4A1 protein expression in
HGF-1 cells co-cultured with KYSE-30 (A) and FLO-1 (B).
No TIMP3 protein could be detected, while COL4A1 was
expressed, but this expression was not significantly altered due to
co-culturing with cancer cells.
(TIF)
Figure S8 Expression of the CAF marker S100A4 in
HGF-1 normal fibroblasts. (A) Co-culture of HGF-1 with
KYSE-30 induces ACTA2, FAP and S100A4, but not CSPG4 gene
expression. (B) Co-culture of HGF-1 with KYSE-30 induces
S100A4, but not FAP, CSPG4 or ACTA2 protein expression. (C)
Overexpression of miR-21 in HGF-1 cells leads to induction of
S100A4, but not of ACTA2, FAP and CSPG4 protein expression.
(D) Downregulating miR-21 in HGF-1 cells reduces S100A4, but
not ACTA2, FAP and CSPG4 protein expression. NC, negative
control; inh, inhibitor.
(TIF)
Methods S1.
(DOC)
Table S1 Gene specific primers used for qRT-PCR
quantification of fibroblastic markers.
(DOCX)
Table S2 LinRegPCR analysis results.
(DOCX)
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